MWM
BNTX icon

Meridian Wealth Management’s BioNTech BNTX Stock Holding History

Meridian Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,748
Closed -$713K – 550
2022
Q4 		$713K Buy
4,748
+2,817
+146% +$433K 0.07% 246
2022
Q3 		$260K Buy
+1,931
New +$295K 0.03% 393

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Meridian Wealth Management's BNTX Position: Q1 2023 in Review

Meridian Wealth Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 4,748 shares — an estimated $713K sold.

Meridian Wealth Management first reported a position in BNTX in Q3 2022 and held it in 2 quarters. The position peaked at $713K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Meridian Wealth Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Meridian Wealth Management sold 4,748 BioNTech shares in Q1 2023, an estimated $713K.
  • Meridian Wealth Management first reported a position in BioNTech in Q3 2022 and held it in 2 quarters.
  • Meridian Wealth Management's BioNTech position peaked at $713K in Q4 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Meridian Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.